NO20040535L - C-2 metylerte derivater av paclitaxel for anvendelse som antitumor-midler - Google Patents

C-2 metylerte derivater av paclitaxel for anvendelse som antitumor-midler

Info

Publication number
NO20040535L
NO20040535L NO20040535A NO20040535A NO20040535L NO 20040535 L NO20040535 L NO 20040535L NO 20040535 A NO20040535 A NO 20040535A NO 20040535 A NO20040535 A NO 20040535A NO 20040535 L NO20040535 L NO 20040535L
Authority
NO
Norway
Prior art keywords
sub
paclitaxel
antitumor agents
methylated derivatives
formula
Prior art date
Application number
NO20040535A
Other languages
English (en)
Norwegian (no)
Inventor
Ezio Bombardelli
Arturo Battaglia
Gabriele Fontana
Samanta Cimitan
Original Assignee
Lndena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lndena Spa filed Critical Lndena Spa
Publication of NO20040535L publication Critical patent/NO20040535L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
NO20040535A 2001-08-07 2004-02-05 C-2 metylerte derivater av paclitaxel for anvendelse som antitumor-midler NO20040535L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI001734A ITMI20011734A1 (it) 2001-08-07 2001-08-07 Derivanti tassanici e procedimenti per la loro preparazione
PCT/EP2002/008185 WO2003013503A1 (en) 2001-08-07 2002-07-23 C-2' methylated derivatives of paclitaxel for use as antitumour agents

Publications (1)

Publication Number Publication Date
NO20040535L true NO20040535L (no) 2004-04-26

Family

ID=11448252

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040535A NO20040535L (no) 2001-08-07 2004-02-05 C-2 metylerte derivater av paclitaxel for anvendelse som antitumor-midler

Country Status (20)

Country Link
US (1) US7153884B2 (pl)
EP (1) EP1423108B1 (pl)
KR (1) KR100894580B1 (pl)
CN (1) CN100370980C (pl)
AT (1) ATE363901T1 (pl)
AU (1) AU2002328942B2 (pl)
BR (1) BR0211770A (pl)
CA (1) CA2456523A1 (pl)
DE (1) DE60220524T2 (pl)
DK (1) DK1423108T3 (pl)
ES (1) ES2287310T3 (pl)
HU (1) HUP0401275A3 (pl)
IL (1) IL160233A0 (pl)
IT (1) ITMI20011734A1 (pl)
MX (1) MXPA04001234A (pl)
NO (1) NO20040535L (pl)
PL (1) PL194975B1 (pl)
PT (1) PT1423108E (pl)
RU (1) RU2287528C2 (pl)
WO (1) WO2003013503A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2706881A1 (en) * 2007-11-30 2009-06-11 Brian Z. Ring Tle3 as a marker for chemotherapy
CN101851231A (zh) * 2010-05-27 2010-10-06 东北林业大学 一种多西紫杉醇新衍生物的合成方法及其在制备抗肿瘤药物中的应用
CN104650012A (zh) * 2013-11-22 2015-05-27 天士力控股集团有限公司 一种紫杉烷类化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
FR2721024B1 (fr) * 1994-06-09 1996-07-12 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
DE60220524D1 (de) 2007-07-19
RU2287528C2 (ru) 2006-11-20
ITMI20011734A1 (it) 2003-02-07
DK1423108T3 (da) 2007-10-01
KR20040030926A (ko) 2004-04-09
HK1066483A1 (en) 2005-03-24
DE60220524T2 (de) 2008-02-07
RU2004103481A (ru) 2005-06-10
US7153884B2 (en) 2006-12-26
WO2003013503A1 (en) 2003-02-20
IL160233A0 (en) 2004-07-25
ES2287310T3 (es) 2007-12-16
EP1423108A1 (en) 2004-06-02
PL194975B1 (pl) 2007-07-31
CA2456523A1 (en) 2003-02-20
AU2002328942B2 (en) 2007-08-30
CN100370980C (zh) 2008-02-27
HUP0401275A3 (en) 2007-05-29
KR100894580B1 (ko) 2009-04-24
ATE363901T1 (de) 2007-06-15
BR0211770A (pt) 2004-07-27
US20040242674A1 (en) 2004-12-02
ITMI20011734A0 (it) 2001-08-07
HUP0401275A2 (hu) 2004-10-28
MXPA04001234A (es) 2004-05-27
EP1423108B1 (en) 2007-06-06
CN1538841A (zh) 2004-10-20
PT1423108E (pt) 2007-08-28
PL367868A1 (pl) 2005-03-07

Similar Documents

Publication Publication Date Title
DK1585739T3 (da) Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer
MXPA06012595A (es) Analogos de amino-tetrazoles y metodos de uso.
ATE283253T1 (de) Substituierte aminopropoxyarylderivate als lxr agonisten
ATE260275T1 (de) Substituierte thien-3-yl- sulfonylamino(thio)carbonyl-triazolin(thi)one
HRP20090195T1 (hr) Inhibitori mitotičkih kinezina
BR0207302A (pt) Trifluorometilpurinas como inibidores da fosfodiesterase 4
EA200601686A1 (ru) Замещенные производные морфолина и тиоморфолина
DK1385515T3 (da) Spiropyrazole forbindelser
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
MX2009003713A (es) Inhibidor de progresion de enfermedad de alzheimer que contiene un compuesto heterociclico con estructura especifica.
EA200600694A1 (ru) Дисульфидные, сульфидные, сульфоксидные и сульфоновые производные циклических сахаров и их применение
DE60336735D1 (de) Neue biologischaktive molekü le
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
DK1644389T3 (da) Pyrinidinforbindelser med phosphonatgrupper som antivirale nukleotidanaloger
NO20061317L (no) Imidazopyridinderivater som induserbare NO-syntaseinhibatorer
BR0208812A (pt) Derivados fenil heterociclil éter como inibidores de recaptação de serotonina
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
ATE239722T1 (de) Benzofurylpiperazine als serotonin-agonisten
NO20050871L (no) 6-amino-1H-indazol- og 4-aminobenzofuranforbindelser som fosfodiesterase 4-inhibitorer
NO20040535L (no) C-2 metylerte derivater av paclitaxel for anvendelse som antitumor-midler
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.
EA200600608A1 (ru) Производные имидазопиридина как ингибиторы индуцируемой no-синтазы
ATE401325T1 (de) C10-carbamoyloxysubstituierte taxane als antitumormittel
MXPA05012279A (es) Derivados de bencil sulfonamida.
SE0402734D0 (sv) Antimiicrobial compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application